Pharmacovigilance and Drug Safety Software Market to Reach US$ 262.02 Mn at a CAGR of 6.4% in 2027 | The Insight Partners

Pharmacovigilance (PV) and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type ( Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software ); Delivery Mode ( On-premise, Cloud-based ); End User ( Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Pharmacovigilance Service Providers ),and Geography

Publication Month: Sep 2019 | Report Code: TIPHC00002557 | No. of Pages: 135 | Category: Pharmaceuticals | Status: Published

The global Pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.

 

Europe is the second largest geographic market and is expected to be the second most significant revenue contributor throughout the forecast period. Increasing pressure to follow safety guidelines set by government authorities such as European Medicines Agency, collaboration between companies for use of advance technology in the field of Pharmacovigilance (PV) and drug safety software.

 

Exhibit: Lucrative Regional Pharmacovigilance (PV) and Drug Safety Software Markets


 

Market Insights

Rising Incidences of Adverse Drug Reactions (ADRs)

Adverse drug reactions (ADRs) is an important public health problem, signifying an important cause of illness and death. Because all drugs have the potential for adverse drug reactions, a risk-benefit analysis is necessary whenever a drug is prescribed. According to the Agency for Healthcare Research and Quality 2018, In the US, 3% to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur from 10% to 20% of admissions; about 10% to 20% of these ADRs are severe. These statistics do not include the number of ADRs that occur in ambulatory and nursing home patients. Although the exact number of ADRs is not specified, ADRs represent a significant public health problem that is, for the most part, preventable. In 2016, 1,238,178 reports related to suspected adverse reactions were collected and managed in EudraVigilance, 339,544 of which originate from the European Economic Area (EEA). European database for adverse drug reaction reports, which Member State and the Agency use for monitoring the safety of authorized medicines on the EU market. EudraVigilance now holds 10.8 million reports referring to 6.7 million cases and therefore is one of the most significant adverse drug reaction databases in the world. Adverse drug reactions (ADRs) reported by a patient or healthcare professional adds to safety monitoring and thus to the safe and effective use of medicines. The increasing amount of data generated through adverse drug reaction report needs to be handled and stored carefully. All these data come in different forms, language, location, etc. To arrange these uniformly the automation systems/software are helpful.

 

Product and services Insights

The global pharmacovigilance (PV) and drug safety software market by delivery mode was led by on-premise. In 2018, this segment held the largest market share in the pharmacovigilance (PV) and drug safety software market, by delivery mode. The segment is also expected to witness growth at a significant rate during the forecast period as on-premise software are therefore best suited for larger pharmaceutical companies with higher budgets

 

Exhibit: Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 


 

PHARMACOVIGILANCE (PV) AND DRUG SAFETY SOFTWARE – MARKET SEGMENTATION

Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type

  • Fully Integrated Software
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software

Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode

  • Cloud-based
  • On-premise

Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User

  • Contract Research Organizations
  • Pharmaceutical and Biotech Companies
  • Business Process Outsourcing

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

Company Profiles

  • AB Cube
  • United Biosource LLC
  • ArisGlobal LLC
  • Sparta Systems
  • Oracle
  • Sarjen Systems Pvt. Ltd
  • EXTEDO
  • ENNOV
  • Maxapplication
  • Online Business Applications, Inc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type

1.3.2       Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode

1.3.3       Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User

1.3.4       Global Pharmacovigilance (PV) and Drug Safety Software Market – By Geography

2.             Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Pharmacovigilance (PV) and Drug Safety Software Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       North America PEST Analysis

4.2.2       Europe PEST Analysis

4.2.3       Asia Pacific PEST Analysis

4.2.4       Middle East & Africa PEST Analysis

4.2.5       South & Central America PEST Analysis

4.3       Expert Opinions

5.             Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1       Rising Incidences Of Adverse Drug Reactions (ADRs

5.1.2       Globalization Of Pharmacovigilance

5.2       Key Market Restraints

5.2.1       Expensive Technology

5.3       Key Market Opportunities

5.3.1       Growth Opportunities in Developing Countries

5.4       Future Trends

5.4.1       Artificial Intelligence In Pharmacovigilance

5.5       Impact Analysis

6.             Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis

6.1       Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis

6.2       Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Global Pharmacovigilance (PV) And Drug Safety Software Analysis– by Software Type

7.1       Overview

7.2       Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2018 & 2027 (%)

7.3       Adverse Event Reporting Software Market

7.3.1       Overview

7.3.2       Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Drug Safety Audits Software

7.4.1       Overview

7.4.2       Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Issue Tracking Software

7.5.1       Overview

7.5.2       Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6       Fully Integrated Software

7.6.1       Overview

7.6.2       Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by Delivery Mode

8.1       Overview

8.2       Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2018 & 2027 (%)

8.3       On-premise Market

8.3.1       Overview

8.3.2       Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Cloud- Based Market

8.4.1       Overview

8.4.2       Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by End User

9.1       Overview

9.2       Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User
2018 & 2027 (%)

9.3       Pharmaceutical and Biotech Companies Market

9.3.1       Overview

9.3.2       Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Contract Research Organizations (CROs) Market

9.4.1.1    Overview

9.4.1.2    Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Business Process Outsourcing (BPO) Firms Market

9.5.1       Overview

9.5.2       Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.1.1    North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to  2027 (US$ Mn)

10.1.2    North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.2.1  North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.2.2  North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.3    North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.4    US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5    US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6    US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.6.1  US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.6.2  US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.1.7    Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.1.7.1  Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8    Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.8.1  Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.8.2  Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

10.1.9    Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.1.9.1  Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

10.1.10.1..... Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.10.2..... Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2    Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.2.1    Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.2.2    Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.3    Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.3.1  Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.3.2  Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.4    Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.2.5    UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6    UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7    UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.7.1  UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.7.2  UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.2.8    Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.2.8.1  Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9    Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.9.1  Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.9.2  Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.9.3  France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.2.11 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.11.1..... France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.11.2..... France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.12.1......... Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.13 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

10.2.13.1......... Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Delivery Mode (US$ Mn)

10.2.13.2......... Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.2.16 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

10.2.16.1....... Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Delivery Mode (US$ Mn)

10.2.16.2....... Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.3    Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.3.1    Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.2    Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.2.1  Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.2.2  Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.3    Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.3.4    Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.3.5    Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.3.6    Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

10.3.6.1  Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.6.2  Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.3.6.3  China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7    China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.3.8    China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.8.1  China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.8.2  China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.3.9    India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.11.1........ India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.11.2........ India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.14.1........ South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.14.2........ South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.17.1.. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.17.2.. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4    Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.4.1    Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2    Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.2.1  Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.2.2  Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4.3    Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.4.4    UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.5    UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6    UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.6.1  UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.6.2  UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

10.4.7    Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1  Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8    Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.8.1  Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.8.2  Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4.9    South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.11.1........ South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.11.2........ South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5    South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.5.1    South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2    South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.3    South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.3.1  South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.3.2  South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5.4    South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.5.5    Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6    Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7    Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.7.1  Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.7.2  Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5.8    Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.5.9    Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

10.5.10 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.10.1....... Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.10.2....... Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User  (US$ Mn)

11.          Pharmacovigilance (PV) and Drug Safety Software Market –Industry Landscape

11.1    Overview

11.2    Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

11.3    Organic Developments

11.3.1    Overview

11.3.2    Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

11.4    Inorganic Developments

11.4.1    Overview

11.4.2    Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

12.          Pharmacovigilance (PV) and Drug Safety Software Market–Key Company Profiles

12.1    AB Cube

12.1.1    Key Facts

12.1.2    Business Description

12.1.3    Financial Overview

12.1.4    Product Portfolio

12.1.5    SWOT Analysis

12.1.6    Key Developments

12.2    UNITED BIOSOURCE LLC

12.2.1    Key Facts

12.2.2    Business Description

12.2.3    Financial Overview

12.2.4    Product Portfolio

12.2.5    SWOT Analysis

12.2.6    Key Developments

12.3    ArisGlobal LLC

12.3.1    Key Facts

12.3.2    Business Description

12.3.3    Financial Overview

12.3.4    Product Portfolio

12.3.5    SWOT Analysis

12.3.6    Key Developments

12.4    Sparta Systems

12.4.1    Key Facts

12.4.2    Business Description

12.4.3    Financial Overview

12.4.4    Product Portfolio

12.4.5    SWOT Analysis

12.4.6    Key Developments

12.5    Oracle

12.5.1    Key Facts

12.5.2    Business Description

12.5.3    Financial Overview

12.5.4    Product Portfolio

12.5.5    SWOT Analysis

12.5.6    Key Developments

12.6    Sarjen Systems Pvt. Ltd

12.6.1    Key Facts

12.6.2    Business Description

12.6.3    Financial Overview

12.6.4    Product Portfolio

12.6.5    SWOT Analysis

12.6.6    Key Developments

12.7    EXTEDO

12.7.1    Key Facts

12.7.2    Business Description

12.7.3    Financial Overview

12.7.4    Product Portfolio

12.7.5    SWOT Analysis

12.7.6    Key Developments

12.8    ENNOV

12.8.1    Key Facts

12.8.2    Business Description

12.8.3    Financial Overview

12.8.4    Product Portfolio

12.8.5    SWOT Analysis

12.8.6    Key Developments

12.9    Maxapplication

12.9.1    Key Facts

12.9.2    Business Description

12.9.3    Financial Overview

12.9.4    Product Portfolio

12.9.5    SWOT Analysis

12.9.6    Key Developments

12.10  Online Business Applications, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary Of Terms



LIST OF TABLES

Table 1.            North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

Table 2.            North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3.            North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 4.            US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5.            US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6.            US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

Table 7.            Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8.            Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9.            Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10.         Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

Table 11.         Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 12.         Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 13.         Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 14.         Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 15.         Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 16.         UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 17.         UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 18.         UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

Table 19.         Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 20.         Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 21.         Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 22.         France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 23.         France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 24.         France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

Table 25.         Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

Table 26.         Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Delivery Mode (US$ Mn)

Table 27.         Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

Table 28.         Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

Table 29.         Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Delivery Mode (US$ Mn)

Table 30.         Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By End User (US$ Mn)

Table 31.         Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 32.         Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 33.         Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 34.         Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Software Type(US$ Mn)

Table 35.         Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Delivery Mode (US$ Mn)

Table 36.         Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 37.         China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 38.         China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 39.         China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 40.         India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 41.         India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 42.         India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 43.         South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 44.         South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 45.         South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 46.         Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 47.         Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 48.         Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 49.         Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 50.         Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 51.         Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 52.         UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 53.         UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 54.         UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 55.         Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 56.         Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 57.         Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 58.         South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 59.         South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 60.         South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 61.         South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 62.         South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 63.         South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 64.         Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 65.         Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 66.         Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 67.         Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 68.         Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 69.         Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 70.         Recent Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market

Table 71.         Recent Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market

Table 72.         Glossary of Terms, Pharmacovigilance (PV) and Drug Safety Software Market


LIST OF FIGURES

Figure 1.          Pharmacovigilance (PV) and Drug Safety Software Market Segmentation

Figure 2.          Pharmacovigilance (PV) and Drug Safety Software Market Segmentation, by Region

Figure 3.          Global Pharmacovigilance (PV) and Drug Safety Software Market Overview

Figure 4.          Adverse Event Reporting Software Segment Held Largest Share Of The Software Type Segment In Pharmacovigilance (PV) and Drug Safety Software Market

Figure 5.          Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6.          Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography (US$ Mn)

Figure 7.          Global Pharmacovigilance (PV) and Drug Safety Software Market- Leading Country Markets (US$ Mn)

Figure 8.          Global Pharmacovigilance (PV) and Drug Safety Software Market, Industry Landscape

Figure 9.          North America : PEST Analysis

Figure 10.       Europe: PEST Analysis

Figure 11.       Asia - Pacific: PEST Analysis

Figure 12.       Middle East & Africa: PEST Analysis

Figure 13.       South & Central America: PEST Analysis

Figure 14.       Impact Analysis of Driver and Restraints Pertaining to Pharmacovigilance (PV) and Drug Safety Software Market

Figure 15.       Global Pharmacovigilance (PV) and Drug Safety Software Market – Revenue Forecasts and Analysis –  2018- 2027

Figure 16.       Global Pharmacovigilance (PV) and Drug Safety Software Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 17.       Prominent Players in the Pharmacovigilance (PV) and Drug Safety Software Market

Figure 18.       Global Pharmacovigilance (PV) and Drug Safety Software Market, by Product & Services 2018 & 2027 (%)

Figure 19.       Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       Global Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2018 & 2027 (%)

Figure 24.       Global Chemical Compounds Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Global Pharmacovigilance (PV) and Drug Safety Software Market, by End User 2018 & 2027 (%)

Figure 27.       Global Pharmaceutical And Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.       Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       Global Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country,  2018 (US$ Mn)

Figure 31.       North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 32.       North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Country (%)

Figure 33.       US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35.       Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.       Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 37.       Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027,  By Country (%)

Figure 39.       UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.       Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 45.       Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 46.       Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 47.       Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.       South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 51.       Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52.       Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 53.       Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.       Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 55.       UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.       Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 57.       South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027  (US$ Mn)

Figure 58.       South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 59.       South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.       South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 61.       Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 62.       Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 63.       Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

 

The List of Companies

  1. Tecan Trading AG
  2. Hamilton Company
  3. TTP Labtech
  4. Frontier Scientific Services
  5. Biosero Inc.
  6. Evotec
  7. Icagen, Inc.
  8. Wuxi Apptec
  9. TCG Lifesciences Pvt. Ltd
  10. BioAscent
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmacovigilance (PV) and drug safety market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmacovigilance (PV) and drug safety market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.